Lenampicillin hydrochloride

盐酸仑氨西林

Report date: 2022/05/11 17:59:58
NME

Base Information

Drug NameLenampicillin hydrochloride
Drug Alias Name仑氨西林Veracillin珍欣TakacillinKBT-1585 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsCommunicable DiseasesBacterial Infections
Global Approved IndicationsCommunicable DiseasesBacterial Infections
Approved Indications in ChinaBacterial Infections
Original Approved Country/TerritoryJapan
Original Approved Date1986/01/01
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShandong Lukang Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShandong Lukang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCommunicable DiseasesBacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01CA
Related LinksKEGG